 | | COMPOUND: C06809 | |
| Entry |
|
|---|
| Name |
Acetylcysteine;
N-Acetyl-L-cysteine
|
|---|
| Formula |
C5H9NO3S
|
|---|
| Exact mass |
163.0303
|
|---|
| Mol weight |
163.1949
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Reaction |
|
|---|
| Enzyme |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
R05CB Mucolytics
R05CB01 Acetylcysteine
D00221 Acetylcysteine (JP18/USP/INN) <JP/US>
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01X OTHER OPHTHALMOLOGICALS
S01XA Other ophthalmologicals
S01XA08 Acetylcysteine
D00221 Acetylcysteine (JP18/USP/INN) <JP/US>
V VARIOUS
V03 ALL OTHER THERAPEUTIC PRODUCTS
V03A ALL OTHER THERAPEUTIC PRODUCTS
V03AB Antidotes
V03AB23 Acetylcysteine
D00221 Acetylcysteine (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Respiratory Tract/Pulmonary Agents
Respiratory Tract Agents, Other
Immunomodulators
Acetylcysteine
D00221 Acetylcysteine (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
223 Expectorants
2233 Cysteines
D00221 Acetylcysteine (JP18/USP/INN)
26 Epidermides
269 Miscellaneous
2699 Others
D00221 Acetylcysteine (JP18/USP/INN)
3 Agents affecting metabolism
39 Other agents affecting metabolism
392 Antidotes
3929 Others
D00221 Acetylcysteine (JP18/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00221 Acetylcysteine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C1c C 18.0486 -16.1759
2 N1b N 19.2610 -15.4705
3 C6a C 16.8419 -15.4705
4 C1b C 18.0428 -17.5750
5 C5a C 20.4736 -16.1759
6 O6a O 15.6236 -16.1643
7 O6a O 16.8362 -14.0657
8 S1a S 16.8303 -18.2628
9 C1a C 21.6802 -15.4705
10 O5a O 20.4619 -17.5750
BOND 9
1 1 2 1 #Up
2 1 3 1
3 1 4 1
4 2 5 1
5 3 6 1
6 3 7 2
7 4 8 1
8 5 9 1
9 5 10 2
|
|---|
|
» Japanese version
|
|